senior management team

Wan Nadiah Binti Wan Mohd Abdullah Yaakob
Chief Executive Officer, Thomson Hospitals Sdn Bhd
Wong Yu Chee
Group Chief Financial Officer, TMC Life Sciences Berhad
Woon Ming Ming
Chief Executive Officer of IVF Technologies Sdn Bhd, TMC Biotech Sdn Bhd , TMC Women’s Specialist Holdings Sdn Bhd, TMC Care Sdn Bhd

Wan Nadiah Binti Wan Mohd Abdullah Yaakob

Chief Executive Officer, Thomson Hospitals Sdn Bhd

Ms. Nadiah Wan, aged 34, was appointed as Chief Executive Officer of Thomson Hospitals Sdn Bhd and Group Chief Corporate Officer of TMC Life Sciences Berhad on 19 June 2017.

Prior to joining Thomson Hospitals Sdn Bhd and the Company, Ms. Nadiah Wan worked in Sunway Medical Centre as Chief Operating Officer (Clinical Services) after being promoted from Director of Business Development and Corporate Communications in October 2016. She started her career at The Boston Consulting Group in 2007 as an Associate Consultant before joining Sunway Group as Manager, Strategy and Corporate Development in 2010.

Ms. Nadiah Wan holds MSc Public Health Nutrition degree qualification from the London School of Hygiene and Tropical Medicine, UK and an AB cum Laude in Biochemical Sciences from Harvard College. She also serves as an Interviewer for Harvard College admissions and is an Exco member of the Harvard Club of Malaysia.

Ms. Nadiah Wan does not hold any directorship in other public companies and listed issuer in Malaysia. She has no family relationship with any Director and/or major shareholder of the Company. She has no convictions of any offences within the past five (5) years and has no public sanctions and/or penalties imposed by the relevant regulatory bodies during the financial year. Also, she has no conflict of interest with the Company.

Wong Yu Chee

Group Chief Financial Officer, TMC Life Sciences Berhad

Mr. Wong Yu Chee has over 22 years’ experience in finance, audit, accounting and tax compliance services in Malaysia and Shanghai. Mr. Wong started his career in 1996 joining a local audit firm as auditor. He then joined Coopers & Lybrand in 1997, now known as PricewaterhouseCoopers (PwC). Mr. Wong spent 8 years in PwC specialised in assurance assignment of large multinational company, public listed companies in various industries, IPO and corporate exercise.

Mr. Wong joined GlaxoSmithKline then as Finance Manager before he left Malaysia joining Ernst & Young Shanghai end 2005. Mr. Wong spent 3 years in Ernst & Young Shanghai focusing on statutory audit assignment, IPO assurance assignment, corporate exercise and US audit assignment until he joined TMF Shanghai end 2008, leading the accounting and tax compliance services in TMF Shanghai for 2 years. Mr. Wong relocated back to Malaysia in 2010, as Director of Accounting & Tax Compliance Services in TMF Malaysia where he spent 5 years helping businesses on accounting and tax compliance including GST advisory and compliance services.

Mr. Wong then joined PCA Corporate Services Sdn Bhd in 2015 as Group Chief Operating Officer before joining TMC Life Sciences Berhad as Group Chief Financial Officer on 3 August 2015. Mr. Wong is a Fellow Member of Association of Chartered Certified Accountants (FCCA), member of Malaysian Institute of Accountants (MIA)-Chartered Accountant (M) and Associate Member of Chartered Tax Institute of Malaysia (ACTIM).

Mr. Wong does not hold any directorship in other public companies and listed issuer in Malaysia. He has no family relationship with any Director and/or major shareholder of the Company. He has no convictions of any offences within the past five (5) years and has no public sanctions and/or penalties imposed by the relevant regulatory bodies during the financial year. Also, he has no conflict of interest with the Company.

Woon Ming Ming

Chief Executive Officer of
  • IVF Technologies Sdn Bhd
  • TMC Biotech Sdn Bhd
  • TMC Women’s Specialist Holdings Sdn Bhd
  • TMC Care Sdn Bhd

Ms. Woon serves as the Chief Executive Officer of TMC Biotech Sdn Bhd, TMC Women’s Specialist Holdings Sdn Bhd, TMC Care Sdn Bhd and IVF Technologies Sdn Bhd. Ms. Woon has over 20 years’ experience in the healthcare industry, with vast experience ranging from operations to business management. Her experience in hospitals has exposed her to the many facets of healthcare, especially fertility treatment, where couples look forward to emotional and mental support. ‘From Hope to Joy’ is something she holds close to her heart. Seeing the joy in every couple when they are successfully pregnant makes her job more fulfilling.

Ms. Woon is a firm believer of perseverance, especially when faced with adversity. Ms. Woon was invited to join TMC Fertility and Women’s Specialist Centre in 2014 as the General Manager. She was subsequently promoted to Chief Executive Officer on 1 March 2017 for the aforesaid subsidiaries of the Company. Her areas of expertise include business development and branding.

Ms. Woon, who holds a MBA majoring in Marketing, oversaw the expansion of the TMC Fertility and Women’s Specialist Centre brand to the Asia Pacific region. Under her leadership, TMC Fertility and Women’s Specialist Centre has been certified by the Reproductive Technology Accreditation Committee (RTAC) and has won multiple international awards including the International Medical Travel Journal’s Fertility Clinic of the Year 2016, 2017 & 2018; Global Health and Travel’s Fertility Service Provider of the Year 2016, 2017 & 2018 and the Frost & Sullivan’s Fertility Centre of the Year 2016.

Ms. Woon does not hold any directorship in other public companies and listed issuer in Malaysia. She has no family relationship with any Director and/or major shareholder of the Company. She has no convictions of any offences within the past five (5) years and has no public sanctions and/or penalties imposed by the relevant regulatory bodies during the financial year. Also, she has no conflict of interest with the Company.